We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · May 02, 2017

GI Safety of Celecoxib vs Naproxen in Patients With Cardiothrombotic Diseases and Arthritis After Upper GI Bleeding

The Lancet

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Gastrointestinal Safety of Celecoxib Versus Naproxen in Patients With Cardiothrombotic Diseases and Arthritis After Upper Gastrointestinal Bleeding (CONCERN): An Industry-Independent, Double-Blind, Double-Dummy, Randomised Trial
Lancet 2017 Apr 11;[EPub Ahead of Print], FKL Chan, JYL Ching, YK Tse, K Lam, GLH Wong, SC Ng, V Lee, KWL Au, PK Cheong, BY Suen, H Chan, KM Kee, A Lo, VWS Wong, JCY Wu, MH Kyaw

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading